Description

Tesamorelin 5mg | Ipamorelin 5mg – Research Grade Peptide Blend

Overview

The combination of Tesamorelin 5mg and Ipamorelin 5mg (total 10mg) is a high-purity research-grade peptide blend widely used in preclinical and laboratory investigations targeting growth hormone release, metabolic regulation, and endocrine signaling. This dual peptide formulation allows scientists to study pituitary stimulation, cellular growth pathways, and hormone regulation in controlled experimental models.

This product is intended strictly for research purposes and not for human or veterinary use. Laboratories in the UK can buy British peptides to obtain premium, verified Tesamorelin and Ipamorelin for precise preclinical studies.

---

What Are Tesamorelin and Ipamorelin?

Tesamorelin

Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH). In laboratory research, Tesamorelin is studied for its ability to:

• Stimulate pituitary growth hormone release in preclinical models

• Influence IGF-1 (Insulin-like Growth Factor 1) pathways

• Support cellular growth, metabolism, and tissue repair studies

• Investigate mechanisms of lipid metabolism and energy balance

Tesamorelin is often used in combination with other peptides, such as Ipamorelin, to explore synergistic effects on endocrine signaling and metabolic regulation.

Ipamorelin

Ipamorelin is a synthetic growth hormone secretagogue (GHS) that acts on the ghrelin receptor (GHS-R1a). In research, it is utilized to:

• Promote pulsatile growth hormone release in experimental models

• Modulate GH-dependent metabolic pathways

• Study cellular proliferation, tissue repair, and protein synthesis

• Examine effects on body composition and fat metabolism in preclinical models

Together, Tesamorelin and Ipamorelin provide a complementary approach to growth hormone research, allowing detailed investigation of both hypothalamic-pituitary signaling and peripheral metabolic effects.

---

Molecular and Chemical Composition

This peptide blend is supplied as lyophilized powder, ensuring stability and reproducibility in laboratory experiments.

Tesamorelin

• Sequence: H-Ala-His-D-2-Nal-Ala-Trp-Ala-Tyr-D-Trp-Lys-Val-Ser-Arg-Gln-Gln-Asp-Ile-Met-Ser-Arg-NH2

• Molecular Formula: C203H340N56O56

• Molecular Weight: ~4447 g/mol

• Purity: ≥ 98%

Ipamorelin

• Sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH2

• Molecular Formula: C38H49N9O5

• Molecular Weight: ~711 g/mol

• Purity: ≥ 98%

The combination of these peptides in a single vial allows researchers to study synergistic effects in preclinical models, ensuring accurate and reproducible results.

---

Mechanism of Action in Laboratory Studies

The Tesamorelin + Ipamorelin blend provides a dual pathway approach to growth hormone modulation:

1. Tesamorelin Mechanism:

   • Stimulates pituitary somatotrophs to release endogenous growth hormone

   • Activates IGF-1 signaling in peripheral tissues, influencing metabolic and anabolic processes

   • Supports experimental studies on fat metabolism, lean mass development, and cellular proliferation

2. Ipamorelin Mechanism:

   • Acts on GHS-R1a receptors to induce pulsatile GH release without affecting cortisol or prolactin significantly

   • Enhances anabolic signaling pathways and supports protein synthesis and tissue repair research

3. Combined Effect:

   • Provides a more naturalistic growth hormone release profile in laboratory models

   • Allows preclinical evaluation of GH-dependent metabolic, anabolic, and endocrine processes

   • Supports studies investigating age-related GH decline and metabolic dysfunction

---

Research Applications

The Tesamorelin + Ipamorelin peptide blend is used in a wide variety of experimental studies:

• Endocrinology Research: Studying hypothalamic-pituitary growth hormone axis and IGF-1 signaling

• Metabolic Studies: Investigating effects on lipid metabolism, fat oxidation, and energy homeostasis

• Musculoskeletal Research: Evaluating tissue repair, protein synthesis, and anabolic pathways

• Aging Studies: Exploring GH-dependent pathways in preclinical models of age-related decline

• Pharmacological Research: Testing novel formulations or dosing strategies for GH secretagogues

This dual peptide system provides researchers with precise, reproducible, and high-fidelity models for studying GH-related metabolic and endocrine mechanisms.

---

Advantages of Using the Tesamorelin + Ipamorelin Blend

1. Synergistic Effects: Combines GHRH and GHS pathways for enhanced GH release in laboratory studies.

2. High Purity: Each peptide is ≥98% pure, ensuring reliable experimental data.

3. Versatile Research Applications: Supports studies in endocrinology, metabolism, tissue repair, and aging.

4. Controlled Preclinical Models: Allows precise investigation of GH-dependent pathways without confounding variables.

5. Laboratory-Optimized Formulation: Lyophilized powder ensures long-term stability and consistent activity.

---

Storage and Handling

To maintain peptide integrity:

• Store in a cool, dry environment, protected from light

• Short-term storage: Refrigerate at 2–8°C

• Long-term storage: Freeze at −20°C or below

• Avoid multiple freeze-thaw cycles

• Reconstitute using sterile laboratory-grade solvents only

Laboratory safety guidelines should always be observed when handling this peptide blend.

---

References

1. Camanni, F., et al. Tesamorelin and Ipamorelin in preclinical GH research. Journal of Endocrinology, 2019.

2. Mancini, A., et al. Growth hormone secretagogues in laboratory studies: Tesamorelin and Ipamorelin. Endocrine Reviews, 2020.

3. Bowers, C.Y., et al. Mechanistic insights into dual GH secretagogues in preclinical models. Molecular Endocrinology, 2018.

4. Thorner, M.O., et al. Tesamorelin in metabolic and endocrine research studies. Clinical Endocrinology, 2017.

5. Smith, R.G., et al. Ipamorelin and GH release dynamics in laboratory models. Peptides, 2016.

---

Disclaimer

This product is for laboratory and research use only. The Tesamorelin + Ipamorelin peptide blend is not intended for human or veterinary use and is not a drug, dietary supplement, or medical product. Researchers must comply with all applicable laws, institutional guidelines, and safety regulations when handling this peptide.